Revenue | ₹178.34Cr |
Net Profits | ₹31.66Cr |
Net Profit Margins | 17.75% |
Senores Pharmaceuticals Ltd’s revenue jumped 64.85% since last year same period to ₹178.34Cr in the Q3 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 6.68% jump in its revenue since last 3-months.
Senores Pharmaceuticals Ltd’s net profit jumped 84.28% since last year same period to ₹31.66Cr in the Q3 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated -2.22% fall in its net profits since last 3-months.
Senores Pharmaceuticals Ltd’s net profit margin jumped 11.79% since last year same period to 17.75% in the Q3 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated -8.35% fall in its net profit margins since last 3-months.
The revenue for Senores Pharmaceuticals Ltd in the Q3 results 2025 was ₹178.34Cr.
The net profit for Senores Pharmaceuticals Ltd in the Q3 results 2025 was ₹31.66Cr.
The net profit margin for Senores Pharmaceuticals Ltd in the Q3 results 2025 was 17.75%.
The revenue for Senores Pharmaceuticals Ltd in the Q3 results 2024 was ₹108.18Cr.
The net profit for Senores Pharmaceuticals Ltd in the Q3 results 2024 was ₹17.18Cr.
The net profit margin for Senores Pharmaceuticals Ltd in the Q3 results 2024 was 15.88%.